Influenza vaccine

...virus-like-particle (VLP) vaccine technology. CPL Biologicals also expects to develop the pandemic H1N1 influenza vaccine candidate in India that Novavax is developing in the United States. About Cadila Pharmaceuticals Ltd. Cadila...

In this article: India, Joint venture, Dengue fever, Chikungunya, Cancer, and Nasdaq

This influenza vaccine supply solution consisting of our VLP technology and portable manufacturing avoids the use of chicken eggs, creates vaccines for emerging strains faster, and promises less expensive, in-border manufacturing capacity.

In this article: VLP, Spain, European Union, Nasdaq, and Europe

...for first time: Azad New Delhi, Nov 6 : An influenza vaccine is for the first time being developed in India that would be effective against the swine flu pandemic, Health Minister Ghulam Nabi Azad said here Friday. "Public health...

In this article: India, H1N1, and New Delhi

...flu and H1N1 pandemic flu vaccines as well as the realization of our technology in Spain and India to create self reliant in-border influenza vaccine supply," stated Rahul Singhvi, President and Chief Executive Officer of Novavax, Inc.

In this article: Balance sheet, Securities and Exchange Commission, Nasdaq, Maryland, India, and Spain

...to market the drug in 100 countries. Meanwhile, Ranbaxy Laboratories, India's biggest drug maker, says it can begin supplies of the anti-influenza vaccine at short notice, should it get any orders. "We produce Oseltamavir API and...

In this article: Hyderabad, New York City, US, and Avian flu

...and pregnant women due to the risk of A (H1N1) virus infection following the Haj Committee of India taking up the issue: "If the influenza vaccine is made available before the Haj pilgrimage, it will be compulsory to inoculate the travellers.

In this article: Saudi Arabian Airlines, Air India, Jaipur, Jaipur, and India

...of product candidates under development; current results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further testing is required before regulatory...

In this article: Joint venture, India, Dengue fever, Chikungunya, U.S. Securities and Exchange Commission, Nasdaq, and Strategic alliance